Feasibility and Timing of Cytoreduction Surgery in Advanced (Metastatic or Recurrent) Gastrointestinal Stromal Tumors During the Era of Imatinib

The prognosis of advanced gastrointestinal stromal tumors (GISTs) was dramatically improved in the era of imatinib. Cytoreduction surgery was advocated as an additional treatment for advanced GISTs, especially when patients having poor response to imatinib or developing resistance to it. However, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Shih-Chun, Liao, Chien-Hung, Wang, Shang-Yu, Tsai, Chun-Yi, Chiang, Kun-Chun, Cheng, Chi-Tung, Yeh, Ta-Sen, Chen, Yen-Yang, MA, Ming-Chun, Liu, Chien-Ting, Yeh, Chun-Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616552/
https://www.ncbi.nlm.nih.gov/pubmed/26091448
http://dx.doi.org/10.1097/MD.0000000000001014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616552/
https://www.ncbi.nlm.nih.gov/pubmed/26091448
http://dx.doi.org/10.1097/MD.0000000000001014

Ejemplares similares